
Genevieve S. Alley
Examiner (ID: 9678, Phone: (571)270-1111 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 843 |
| Issued Applications | 465 |
| Pending Applications | 100 |
| Abandoned Applications | 305 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14280469
[patent_doc_number] => 20190137519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => INHIBITING CHRONIC BLOOD AND NEPHROLOGICAL DISORDERS USING LYSINE-BASED SUPPLEMENTS
[patent_app_type] => utility
[patent_app_number] => 15/870822
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870822 | Inhibiting chronic blood and nephrological disorders using lysine-based supplements | Jan 11, 2018 | Issued |
Array
(
[id] => 14563729
[patent_doc_number] => 20190209471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => BUFFERED COMPOSITIONS AND METHODS FOR THEIR USE IN SURFACE TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 15/868357
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868357
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/868357 | BUFFERED COMPOSITIONS AND METHODS FOR THEIR USE IN SURFACE TREATMENTS | Jan 10, 2018 | Abandoned |
Array
(
[id] => 12878464
[patent_doc_number] => 20180184663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => ACID COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/855068
[patent_app_country] => US
[patent_app_date] => 2017-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15855068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/855068 | Acid compositions and uses thereof | Dec 26, 2017 | Issued |
Array
(
[id] => 15646853
[patent_doc_number] => 20200085956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => NOVEL ANTIOXIDANTS FOR COSMETICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING GLYCEROL ALKYL ETHERS
[patent_app_type] => utility
[patent_app_number] => 16/471027
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471027 | NOVEL ANTIOXIDANTS FOR COSMETICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING GLYCEROL ALKYL ETHERS | Dec 20, 2017 | Abandoned |
Array
(
[id] => 12831457
[patent_doc_number] => 20180168991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => STYLING AGENT WITH IMPROVED LONG-TERM HOLD AND DEGREE OF HOLD
[patent_app_type] => utility
[patent_app_number] => 15/847931
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15847931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/847931 | STYLING AGENT WITH IMPROVED LONG-TERM HOLD AND DEGREE OF HOLD | Dec 19, 2017 | Abandoned |
Array
(
[id] => 15338973
[patent_doc_number] => 10525143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Conjugate of polyethylene glycol and anesthetic, and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 15/848987
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7987
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848987
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/848987 | Conjugate of polyethylene glycol and anesthetic, and preparation method thereof | Dec 19, 2017 | Issued |
Array
(
[id] => 18101254
[patent_doc_number] => 11541125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Noncrushable pill formulations
[patent_app_type] => utility
[patent_app_number] => 16/469786
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 28
[patent_no_of_words] => 22881
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469786 | Noncrushable pill formulations | Dec 18, 2017 | Issued |
Array
(
[id] => 15144717
[patent_doc_number] => 20190350836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COSMETIC COMPOSITION COMPRISING SOLID FATTY SUBSTANCES AND A GELLING POLYMER
[patent_app_type] => utility
[patent_app_number] => 16/461557
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461557 | COSMETIC COMPOSITION COMPRISING SOLID FATTY SUBSTANCES AND A GELLING POLYMER | Dec 14, 2017 | Abandoned |
Array
(
[id] => 16774259
[patent_doc_number] => 10985383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Scalable, massively parallel process for making micro-scale functional particles
[patent_app_type] => utility
[patent_app_number] => 15/842135
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5032
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842135 | Scalable, massively parallel process for making micro-scale functional particles | Dec 13, 2017 | Issued |
Array
(
[id] => 16769639
[patent_doc_number] => 10980721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Cosmetic product to prevent body odor with an improved long-term effect
[patent_app_type] => utility
[patent_app_number] => 15/838377
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7503
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 295
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15838377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/838377 | Cosmetic product to prevent body odor with an improved long-term effect | Dec 11, 2017 | Issued |
Array
(
[id] => 13354455
[patent_doc_number] => 20180228767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => Choline Esters
[patent_app_type] => utility
[patent_app_number] => 15/837171
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837171
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837171 | Choline Esters | Dec 10, 2017 | Abandoned |
Array
(
[id] => 15586119
[patent_doc_number] => 20200069594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => HYBRID EXOSOMAL-POLYMERIC (HEXPO) NANO-PLATFORM FOR DELIVERY OF RNAI THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 16/467401
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467401 | HYBRID EXOSOMAL-POLYMERIC (HEXPO) NANO-PLATFORM FOR DELIVERY OF RNAI THERAPEUTICS | Dec 7, 2017 | Pending |
Array
(
[id] => 12601563
[patent_doc_number] => 20180092351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => WETTING AGENTS FOR ASEPTIC FILLING
[patent_app_type] => utility
[patent_app_number] => 15/834370
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15834370
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/834370 | Wetting agents for aseptic filling | Dec 6, 2017 | Issued |
Array
(
[id] => 13311487
[patent_doc_number] => 20180207280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => STABLE TRANSDERMAL AMPHETAMINE COMPOSITIONS AND METHODS OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 15/827190
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15827190
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/827190 | Stable transdermal amphetamine compositions and methods of manufacture | Nov 29, 2017 | Issued |
Array
(
[id] => 16733809
[patent_doc_number] => 10959426
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-30
[patent_title] => Pathogen eliminating article and methods of manufacturing and using the same
[patent_app_type] => utility
[patent_app_number] => 15/824367
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 8114
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824367
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/824367 | Pathogen eliminating article and methods of manufacturing and using the same | Nov 27, 2017 | Issued |
Array
(
[id] => 14273597
[patent_doc_number] => 20190134083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => PREVENTION OF PROTEIN GLYCATION USING LYSINE/ZINC SUPPLEMENTS
[patent_app_type] => utility
[patent_app_number] => 15/817574
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817574 | Prevention of protein glycation using lysine/zinc supplements | Nov 19, 2017 | Issued |
Array
(
[id] => 16786030
[patent_doc_number] => 10988442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/806952
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15362
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806952 | Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use | Nov 7, 2017 | Issued |
Array
(
[id] => 12231841
[patent_doc_number] => 20180064704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE'
[patent_app_type] => utility
[patent_app_number] => 15/805961
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18833
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15805961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/805961 | IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE | Nov 6, 2017 | Abandoned |
Array
(
[id] => 14182795
[patent_doc_number] => 20190111102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => Oral Delivery System for Collagen Peptides
[patent_app_type] => utility
[patent_app_number] => 15/803787
[patent_app_country] => US
[patent_app_date] => 2017-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15803787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/803787 | Oral Delivery System for Collagen Peptides | Nov 4, 2017 | Abandoned |
Array
(
[id] => 14273561
[patent_doc_number] => 20190134065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => COMPOUNDS FOR PRENATAL TREATMENT COMPRISING A NATAL VITAMIN AND ASPIRIN AND METHODS FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/802542
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802542
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/802542 | Compounds for prenatal treatment comprising a natal vitamin and aspirin and methods for making and using the same | Nov 2, 2017 | Issued |